HSBC · NYSE
The supplied consensus is Hold across 10 analysts, with a mean target of $106.28, just above the supplied $106.04 closing price. Low and high targets are unavailable, so the width of the target spread cannot be measured. No named analyst is identified as most or least bullish, and the evidence does not document the direction of target or rating revisions during the past week. The substantive disagreement that can be supported is strategic rather than broker-specific: HSBC’s stronger second-quarter revenue and pretax-profit performance, particularly its Asia strategy, supports the constructive case, while global tensions and the uncertain financial effect of retail exits and the Australian portfolio sale support restraint.
